Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hubbard

Showing results (241-250 of 255) with videos related to

Pageof 26
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 11, 2007
Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR)Robert D Hubbard, Nwe Y Bamaung, Fabio Palazzo, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinasesGary T Wang, Robert A Mantei, Robert D Hubbard, et al.
Personalized Medicine|March 17, 2021
Pharmacogenomic testing for mental health (Part II): qualitative analysis of early adopter prescriber perceptionsBeatriz Manzor Mitrzyk, Melissa A Plegue, Reema Kadri, et al.
Archives of Internal Medicine|March 16, 2011
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohortIan H de Boer, Tessa C Rue, Patricia A Cleary, et al.
Neuron|May 4, 2023
Dually innervated dendritic spines develop in the absence of excitatory activity and resist plasticity through tonic inhibitory crosstalkMason S Kleinjan, William C Buchta, Roberto Ogelman, et al.
BMC Cancer|September 8, 2009
Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605William N Pappano, Paul M Jung, Jonathan A Meulbroek, et al.
Neuron|November 17, 2022
Dually innervated dendritic spines develop in the absence of excitatory activity and resist plasticity through tonic inhibitory crosstalkMason S Kleinjan, William C Buchta, Roberto Ogelman, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinasesRobert D Hubbard, Nwe Y Bamaung, Steve D Fidanze, et al.
Nature|April 8, 2011
Suppression of lung adenocarcinoma progression by Nkx2-1Monte M Winslow, Talya L Dayton, Roel G W Verhaak, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2009
Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitorsAlex G Waterson, Kimberly G Petrov, Keith R Hornberger, et al.
Pageof 26

Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
Bioorganic & Medicinal Chemistry Letters|August 11, 2007
Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR)Robert D Hubbard, Nwe Y Bamaung, Fabio Palazzo, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinasesGary T Wang, Robert A Mantei, Robert D Hubbard, et al.
Personalized Medicine|March 17, 2021
Pharmacogenomic testing for mental health (Part II): qualitative analysis of early adopter prescriber perceptionsBeatriz Manzor Mitrzyk, Melissa A Plegue, Reema Kadri, et al.
Archives of Internal Medicine|March 16, 2011
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohortIan H de Boer, Tessa C Rue, Patricia A Cleary, et al.
Neuron|May 4, 2023
Dually innervated dendritic spines develop in the absence of excitatory activity and resist plasticity through tonic inhibitory crosstalkMason S Kleinjan, William C Buchta, Roberto Ogelman, et al.
BMC Cancer|September 8, 2009
Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605William N Pappano, Paul M Jung, Jonathan A Meulbroek, et al.
Neuron|November 17, 2022
Dually innervated dendritic spines develop in the absence of excitatory activity and resist plasticity through tonic inhibitory crosstalkMason S Kleinjan, William C Buchta, Roberto Ogelman, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinasesRobert D Hubbard, Nwe Y Bamaung, Steve D Fidanze, et al.
Nature|April 8, 2011
Suppression of lung adenocarcinoma progression by Nkx2-1Monte M Winslow, Talya L Dayton, Roel G W Verhaak, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2009
Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitorsAlex G Waterson, Kimberly G Petrov, Keith R Hornberger, et al.
Pageof 26